420 minutes
The Business of Biotech explores the business considerations that drive company strategies. Gain a deeper understanding of how companies are funded, which government agencies regulate the sector and how different departments need to be aligned to be successful. This day provides an overview of how the industry works, why it works the way it does, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side, this course delivers a sound, basic understanding of the “business of biotech”.
Course content includes: From Discovery to Commercialization, Role of Non-profit Basic Research, Intellectual Property Considerations & Funding Sources, Organizational Characteristics, and The Ecosystem and the Future of Biopharma

Speakers

Imran Nasrullah - Vice President & Head, Collaborate to Cure Hub, Business Development & Licensing, US | Bayer